S T A T E O F N E W Y O R K
________________________________________________________________________
6551
2025-2026 Regular Sessions
I N S E N A T E
March 17, 2025
___________
Introduced by Sen. BAILEY -- read twice and ordered printed, and when
printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to including image-guided
biopsies under certain insurance coverage for breast cancer screening
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Item (iv) of subparagraph (A) of paragraph 11 of subsection
(i) of section 3216 of the insurance law, as amended by chapter 424 of
the laws of 2024, is amended to read as follows:
(iv) upon the recommendation of a physician, screening and diagnostic
imaging, including diagnostic mammograms, breast ultrasounds, IMAGE-
GUIDED BREAST BIOPSIES, or magnetic resonance imaging, recommended by
nationally recognized clinical practice guidelines for the detection of
breast cancer. For the purposes of this item, "nationally recognized
clinical practice guidelines" means evidence-based clinical practice
guidelines informed by a systematic review of evidence and an assessment
of the benefits, and risks of alternative care options intended to opti-
mize patient care developed by independent organizations or medical
professional societies utilizing a transparent methodology and reporting
structure and with a conflict of interest policy.
§ 2. Item (v) of subparagraph (A) of paragraph 11 of subsection (l) of
section 3221 of the insurance law, as amended by chapter 424 of the laws
of 2024, is amended to read as follows:
(v) upon the recommendation of a physician, screening and diagnostic
imaging, including diagnostic mammograms, breast ultrasounds, IMAGE-
GUIDED BREAST BIOPSIES, or magnetic resonance imaging, recommended by
nationally recognized clinical practice guidelines for the detection of
breast cancer. For the purposes of this item, "nationally recognized
clinical practice guidelines" means evidence-based clinical practice
guidelines informed by a systematic review of evidence and an assessment
of the benefits, and risks of alternative care options intended to opti-
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD10190-04-5
S. 6551 2
mize patient care developed by independent organizations or medical
professional societies utilizing a transparent methodology and reporting
structure and with a conflict of interest policy.
§ 3. Subparagraph (E) of paragraph 1 of subsection (p) of section 4303
of the insurance law, as amended by chapter 424 of the laws of 2024, is
amended to read as follows:
(E) upon the recommendation of a physician, screening and diagnostic
imaging, including diagnostic mammograms, breast ultrasounds, IMAGE-
GUIDED BREAST BIOPSIES, or magnetic resonance imaging, recommended by
nationally recognized clinical practice guidelines for the detection of
breast cancer. For the purposes of this subparagraph, "nationally recog-
nized clinical practice guidelines" means evidence-based clinical prac-
tice guidelines informed by a systematic review of evidence and an
assessment of the benefits, and risks of alternative care options
intended to optimize patient care developed by independent organizations
or medical professional societies utilizing a transparent methodology
and reporting structure and with a conflict of interest policy; and
§ 4. This act shall take effect January 1, 2026 and shall apply to all
policies and contracts issued, renewed, modified, altered or amended on
or after such date; provided, however, that if chapter 424 of the laws
of 2024 shall not have taken effect on or before such date then this act
shall take effect on the same date and in the same manner as such chap-
ter of the laws of 2024 takes effect.